Literature DB >> 1572378

Accumulation of immunoglobulin G at focal sites of inflammation.

M Juweid1, H W Strauss, H Yaoita, R H Rubin, A J Fischman.   

Abstract

To evaluate the factors responsible for the accumulation of indium-111 immunoglobulin G (111In-IgG) at sites of inflammation, sequential measurements of tissue blood volume, interstitial fluid volume and accumulation of radiolabelled albumin and IgG were made in rats following Escherichia coli infection in the thigh. Compared with normal thigh muscle, there was approximately two-fold increase in interstitial fluid volume and approximately 1.5-fold increase in plasma and red blood cell volumes in infected muscle. For both proteins, there was a fivefold increase in influx rate constant (kin) in infected muscle. In normal muscle, the interstitial fluid concentration of labelled human serum albumin (111In-HSA) was significantly higher than that of 111In-IgG (P less than 0.01). In contrast, the concentrations in infected muscle were nearly identical. The concentration ratios (infected to normal muscle) were 1.7:1 for HSA and 3:1 for IgG. These data suggest that the infection imaging properties of 111In-IgG are related to expansion of the space available to macromolecules in infected tissue and increased transport into this space. At clinically important imaging times (24-48 h after injection), the higher target-to-background ratio of 111In-IgG compared with 111In-HSA is not due to the higher accumulation IgG in infected tissue but rather to the higher accumulation of HSA in normal tissue.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572378     DOI: 10.1007/bf00173275

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  21 in total

1.  Vascular-extravascular exchange of II31 plasma proteins in the rat.

Authors:  W C DEWEY
Journal:  Am J Physiol       Date:  1959-08

2.  Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

Authors:  M J Abrams; M Juweid; C I tenKate; D A Schwartz; M M Hauser; F E Gaul; A J Fuccello; R H Rubin; H W Strauss; A J Fischman
Journal:  J Nucl Med       Date:  1990-12       Impact factor: 10.057

3.  A new radiochemical method to determine the stability constants of metal chelates attached to a protein.

Authors:  K M Subramanian; W Wolf
Journal:  J Nucl Med       Date:  1990-04       Impact factor: 10.057

4.  Detection of inflammatory lesions with radiolabelled immunoglobulins.

Authors:  D Blok; M von Ogtrop; J W Arndt; J A Camps; R I Feitsma; W Goedemans; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

5.  Action of histamine on the mesenteric microvasculature.

Authors:  J Fox; F Galey; H Wayland
Journal:  Microvasc Res       Date:  1980-01       Impact factor: 3.514

6.  Simultaneous fluorescence and electron microscopical detection of bradykinin induced macromolecular leakage.

Authors:  D Hultström; E Svensjö
Journal:  Bibl Anat       Date:  1977

7.  99mTc-labelled polyclonal human immunoglobulin for localization of inflammatory sites--early in vitro-results.

Authors:  A Saptogino; W Becker; F Wolf
Journal:  Nuklearmedizin       Date:  1990-03       Impact factor: 1.379

8.  Dimensions of postcapillary venules sensitive to bradykinin and histamine-induced leakage of macromolecules.

Authors:  E Svensjö; K E Arfors
Journal:  Ups J Med Sci       Date:  1979       Impact factor: 2.384

9.  111In-labeled nonspecific immunoglobulin scanning in the detection of focal infection.

Authors:  R H Rubin; A J Fischman; R J Callahan; B A Khaw; F Keech; M Ahmad; R Wilkinson; H W Strauss
Journal:  N Engl J Med       Date:  1989-10-05       Impact factor: 91.245

10.  Blood volume in the rat.

Authors:  H B Lee; M D Blaufox
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

View more
  12 in total

1.  Imaging inflammation with human polyclonal immunoglobulin: not looked for but discovered.

Authors:  F H Corstens; R A Claessens
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Clinical pharmacology considerations in biologics development.

Authors:  Liang Zhao; Tian-hua Ren; Diane D Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-24       Impact factor: 6.150

Review 3.  The uptake mechanisms of inflammation- and infection-localizing agents.

Authors:  W J Oyen; O C Boerman; C J van der Laken; R A Claessens; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1996-04

4.  Bone scintigraphy versus human immunoglobulin scintigraphy in the clinical investigation of psoriatic arthropathy.

Authors:  M Caglar; J L Moretti; M C Boissier
Journal:  Eur J Nucl Med       Date:  1994-11

5.  Specific antibody uptake in tuberculosis?

Authors:  W J Oyen; R A Claessens; O C Boerman; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1993-06

6.  Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury.

Authors:  L Prat; G Torres; I Carrió; M Roca; V Riambau; L Berná; M Estorch; I Ferrer; C García
Journal:  Eur J Nucl Med       Date:  1993-12

Review 7.  Investigation of joint disease.

Authors:  M V Merrick
Journal:  Eur J Nucl Med       Date:  1992

Review 8.  The contribution of nuclear medicine to the patient with infection.

Authors:  W Becker
Journal:  Eur J Nucl Med       Date:  1995-10

Review 9.  New agents for scintigraphy in rheumatoid arthritis.

Authors:  M H de Bois; E K Pauwels; F C Breedveld
Journal:  Eur J Nucl Med       Date:  1995-11

10.  Immunoscintigraphy in the detection of tuberculosis with radiolabelled antibody fragment against Mycobacterium bovis bacillus Calmette-Guérin: a preliminary study in a rabbit model.

Authors:  J D Lee; K H Shin; S N Cho; J S Shin; M G Lee; W I Yang; C Y Park; H S Yoo; J T Lee; O D Awh
Journal:  Eur J Nucl Med       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.